news
Fenfluramine found effective in preventing drop seizures from LGS
Phase III trial shows fenfluramine as an adjunct to existing anti-epileptic treatment is effective in reducing the frequency of drop seizures from Lennox-Gastaut Syndrome (LGS).
List view / Grid view
Lennox Gastaut syndrome (LGS)
news
Epidyolex available to patients through the NHS from today
Epidyolex, which contains cannabidiol, can now be prescribed by doctors to epilepsy patients in the UK through the NHS.
news
NHS England approves the use of two cannabis-based drugs
Following guidance from the drugs advisory body NICE, two cannabis-based medications have been approved for treatment by the NHS in England.
news
EPIDYOLEX® receives marketing authorisation in Europe
The cannabidiol-based treatment EPIDYOLEX has been granted marketing authorisation from the European Commission.
